Camilla Mittelholzer

Effect of Macitentan on Morbidity and Mortality in Pulmonary Arterial Hypertension (PAH): Results From the SERAPHIN Trial

A. Torbicki, H. Ghofrani, G. Simonneau, 2012 .

Macitentan and morbidity and mortality in pulmonary arterial hypertension.

Z. Jing, A. Torbicki, H. Ghofrani, 2013, The New England journal of medicine.

Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial

A. Torbicki, H. Ghofrani, G. Simonneau, 2013 .

Reduction Of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan In The Randomized Controlled Trial Seraphin

A. Torbicki, O. Sitbon, L. Rubin, 2013 .

Influenza virus : Protection and adaptation

Camilla Mittelholzer, C. M. Mittelholzer, 2006 .

Influenza virus : Protection and adaptation

Camilla Mittelholzer, 2006 .